Showing results (121-130 of 364) with videos related to

Sort By:
Pageof 37
Gastroenterology|October 5, 2007
Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patientsChien-Hung Chen, Chao-Hung Hung, Chuan-Mo Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 3, 2016
Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapyJing-Houng Wang, Yi-Hao Yen, Chih-Chien Yao, et al.
Journal of Hepatology|November 22, 2005
Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapyChien-Hung Chen, Chuan-Mo Lee, Sheng-Nan Lu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 22, 2026
Delta-like 1 homologue (DLK1) predicts clinical outcomes in patients with hepatocellular carcinomaKuan-Fu Huang, Tian-Huei Chu, Kuo-Chin Chang, et al.
Vaccine|February 3, 2009
Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central TaiwanJung-Ta Kao, Jing-Houng Wang, Chao-Hung Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 12, 2011
Reversal of hypolipidemia in chronic hepatitis C patients after successful antiviral therapyYuan-Hung Kuo, Tang-Wei Chuang, Chao-Hung Hung, et al.
European Journal of Clinical Investigation|September 15, 2011
Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantationKing-Wah Chiu, Toshiaki Nakano, Tsung-Hui Hu, et al.
The Journal of Antimicrobial Chemotherapy|April 27, 2013
Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutantsShih-Cheng Yang, Chuan-Mo Lee, Tsung-Hui Hu, et al.
Digestive Diseases and Sciences|May 22, 2014
High risk of hepatitis B virus reactivation in nucleos(t)ide analogue-induced hepatitis B e antigen seroconverters older than 40 yearsLi-Fu Kuo, Chuan-Mo Lee, Chao-Hung Hung, et al.
American Journal of Cancer Research|March 14, 2025
Comparing health insurance-reimbursed lenvatinib and self-paid atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinomaYuan-Hung Kuo, Yen-Hao Chen, Ming-Chao Tsai, et al.
Pageof 37